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Objective:  To  determine  the  transfer  of  2-naphthol  (2-NPH)  in fullterm  human  placental  tissues.
Methods:  Six  placentas  were  studied.  The  ex-vivo  dual  closed-loop  human  placental  cotyledon  perfusion
model  was  used.  2-NPH  was  added  to  the  perfusate  in the maternal  compartment.  Samples  were  obtained
from  the maternal  and  fetal  up to 360  min  measuring.
Results:  The  mean  fetal  weight  was  2880  ±  304.2  g.  Mean  perfused  cotyledon  weight was  26.3  (±5.5) g.
All  unperfused  placental  tissue  samples  contained  NPH  with  a  mean  level  of  7.98 (±1.73)  g\g compared
to  a mean  of  15.58  (±4.53)  g\g after  360  min  perfusion.  A rapid drop  in  maternal  2-NPH  concentration
was observed;  from  5.54  g\g in  the  ﬁrst  15  min  and  13.8  g\g in  360  min.  The  fetal  side  increased  fromuman
lacenta
0.65  g\g  in  the initial  15  min  to 1.5 g\g  in  360  min.  The  transfer  rate  of NPH  was much  lower  than  that
of antipyrine.
Conclusion:  2-NPH  has  the ability  to  rapidly  across  the  placenta  from  the  maternal  to the  fetal  com-
partment  within  15  min.  The  placenta  seems  to  play  a  role in  limiting  the  passage  of 2-NPH  in the  fetal
compartment.
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
Polycyclic aromatic hydrocarbons (PAHs) are a large group of
hemicals that are widely found in our environment and consid-
red as potent atmospheric pollutants as many of their compounds
ave been identiﬁed as carcinogenic, mutagenic, and teratogenic
14,16,17]. They are released into the environment as a result of
ncomplete combustion of organic materials and carbon-containing
uels such as wood, coal, and diesel [37].
Naphthalene (NAP), a volatile polycyclic considered as one of
he simplest PAH chemicals., detected at large quantities indoors
nd outdoors due to solvent-related emissions, renovations, house-
old products, and pesticides [6–26]. The initial metabolites are
poxides which are cyclic ether with three ring atoms. They are
elatively unstable and undergo spontaneous rearrangement into
-naphthol or 2-naphthol (1 and 2-NPH), which conjugate to either
lucouronides or sulphates and are excreted in the urine [7].
Animal studies have shown that NAP is carcinogenic and embry-
toxic [33]. The fetus is especially susceptible to the effects of toxic
∗ Corresponding author. Fax: +971 3 7672067.
E-mail address: hmirghani@uaeu.ac.ae (H. Mirghani).
ttp://dx.doi.org/10.1016/j.toxrep.2015.05.011
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
agents because of its immature and underdeveloped defense mech-
anisms. Hence, exposure during pregnancy can have a negative
effect on fetal growth and development and even increase the sus-
ceptibility to diseases later in life. In-vitro experiments on human
cord blood cells suggest that NAP, in particular its metabolites,
modiﬁes cord blood gene expression. The result is down-regulation
of genes involved in the differentiation of immunocompetent cells,
and overexpression of oncogenes in cell proliferation and cell cycle
progression, ultimately stimulating cell proliferation [9]. NAP itself
does not seem to affect the fetus. Once absorbed, is rapidly dis-
tributed throughout the body with little accumulation in any tissue
[21]. However, its metabolites (NPH) are toxic. Therefore, NAP is
not considered to be cytotoxic or genotoxic without metabolic
activation [7,3]. The exact amount of metabolites that can cross
the placental barrier has not been determined. The metabolizing
enzymes expressed in the placenta and the wide variety of trans-
porters might have signiﬁcant consequences on the transport of
xenobiotics and their effect on the fetus [34]. The placental bar-
rier can limit the delivery of toxic compounds protecting the fetus
against their harmful effects [23]. Several mechanisms are sug-
gested, including uptake, storage, and reﬂux [11].
In this study, we aim to determine the transfer of 2-NPH in full-
term human placental tissues. The outcome of this study might
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Table 1
shows glucose consumption, lactate production, HCG secretion as evidence of pla-
centa viability and metabolic activity.
Maternal Fetal
Glucose consumption(mol/g/min) 0.42 ± 0.04 0.35 ± 0.0.0458 H. Mirghani et al. / Toxico
elp in the development of maternal environmental health related
uidelines
. Materials & methods
This study was approved by the Al Ain Medical District
uman Research Ethics Committee (Al Ain Medical District Human
esearch Ethics Committee (AAMDHREC) – Protocol No. 11/58 –
aphthalene transfer across the human placenta: A human pla-
enta perfusion study). Written consents were obtained from each
regnant woman.
.1. Placental perfusion
Six placentas were obtained from women undergoing elective
aesarean section or vaginal delivery at term.
The placentas were transported to the laboratory within 30 min.
e adopt methods described by Schneider et al. [15,25]. In sum-
ary, a suitable cotyledon was selected and the fetal vessels were
atheterized with a French catheter. The perfusate which has
een used composed of a synthetic tissue culture medium M199
edium Sigma, circulate through the fetal side at a ﬂow rate of
 ml/min delivered by a digitally controlled pump at a pressure not
igher than 60 mmHg. For the delivery of maternal perfusate, three
atheters were directly introduced into the intervillous space at a
epth of 0.5–.0 cm.  Perfusion of the intervillous space was  started
t a ﬂow rate of 12 ml/min. Maternal perfusate was  equilibrated
ith 95% O2 and 5% CO2 and fetal perfusate was equilibrated with
5% N and 5% CO2 after 20 min  both circuits were closed. The per-
usate in the maternal side was replaced by fresh perfusate contains
-NPH Sigma–Aldrich and antipyrine at 0.05 g\l. The concentra-
ion of 2-NPH used for perfusion is based on the recommendation
f the Human Biomonitoring Commission of the German Federal
nvironment Agency, where an upper margin of reference value
f exposure for adult non- smokers to 2-NPH in urine should be
ess than 20 g/l [35]. The perfusion was then continued for six
ours. Samples were obtained from the maternal and fetal circu-
ations at 15, 30, 60, 120, 240, and 360 min  and stored at −80 ◦C.
he glucose and lactate levels were measured using Rx Monza
linical analyzer, Randox, laboratories; UK and -human chorionic
onadotropin (-hCG) secretion was measured using DRG diag-
ostics kits, DRG Instrument GMBH, Germany 2-NPH transfer and
ntipyrine transfer were measured by HPLC.
.2. Placental tissue extraction
Three samples from the placenta, weighing 1 g each, were taken
rom both unperfused and perfused cotyledon and stored at –20 ◦C
ntil analysis. Tissues samples were homogenized (Ultra Turrax®
KA, Werke, Germany) for 1 min  at 15,000 rpm on ice. With addition
f 2 mL  of ACN –20% acetonitrile: water. The homogenate were then
entrifuged at 13,000 rpm and the supernatant were collected and
tored in −20 ◦C for further analysis using HPLC [19].
.3. HPLC analysis
All reagents used were HPLC grade Merck, Germany HPLC
ethod as described [18]. was used for antipyrine The dried extract
as dissolved in 200 l of the mobile phase. Chromatographic sep-
ration were performed on HPLC system Waters Alliance, USA.
or 2NH detection, a stock solution of concentration of 1 g/ml,
00 g/ml, and 1 mg/ml  of 2NPH in acetonitrile HPLC grade were
repared and stored at −20 ◦C until the assay. For each run 20 l
as injected.Lactate production (mol/g/min) 0.49 ± 0.14 0.31 ± 0.06
HCG (mU/g/min) 40.8 ± 7.3
2.4. Calculations
Statistical analysis was  performed using the one-way or two-
way ANOVA. Values of p less than 0.05 were taken as statistically
signiﬁcant. The transfer percentage from maternal to fetal circula-
tion was calculated by the following formula [2]:
100 × Fc × Fv/[(Fc × Fv) + (Mc  × Mv)], where Fc = fetal concentra-
tion, Mc  = maternal concentration, Fv is fetal perfusate volume, and
Mv = maternal perfusate volume.
FM ratio, calculated for the ﬁgures, is the ratio of fetal concen-
tration to maternal concentration.
Transfer index was calculated by dividing the transfer percent-
age of 2-NPH with that of antipyrine. All values are expressed as a
mean ± sd.
Glucose consumption was measured by the following formula:
Glucose consumption = glucose level of perfusate at
360 min  − glucose level at initial time and normalized with
time and tissue weight. Lactate production was measured using
the same formula [8].
3. Results
A total of 6 term placentas were perfused. The mean pregnant
women age was 27.6 ± 6.0 years, with a mean maternal weight at
delivery of 83.1 ± 18.3 and mean fetal weight was 2880 ± 304.2 g.
The mean weight of the perfused cotyledon was  26.3 ± 5.5 g. The
perfusate pH ranged from 7.2 to 7.4, and the ﬂuid shift between the
fetal and maternal compartments was  less than 3 ml/h. Evidence
of placenta viability and metabolic activity throughout the perfu-
sion was  assured by the constant glucose and lactate production
(Table 1). The glucose consumption is calculated according to the
method described by Di Santo et al. [8]:
Glucose consumption = glucose level of perfusate at
360 mins − glucose level at initial time and normalized with
time and tissue weight
All unperfused placental tissue samples contained NPH with
a mean level of 7.98 ± 1.73 g\g compared to a mean of
15.58 ± 4.53 g/g after 360 min  of perfusion.
The initial drop in the concentration of NPH in the maternal
compartment was  rapid. It dropped 5.54 g/g in the ﬁrst 15 min  and
13.8 g/g in 360 min. However, the increase of NPH concentration
on the fetal side was much slower. The increase in the initial 15 min
was as low as 0.65 g/g and increased only to 1.5 g/g in 360 min
(Fig. 1).
The transfer rate of NPH was much lower than that of antipyrine.
The highest transfer index was at 120 min  (Table 2).
4. Discussion
Pregnant women exposed to PAH during pregnancy show a
signiﬁcant increase in the levels of chromosomal aberrations in
neonatal cord blood samples [20]. NPHs (both 1 and 2 isomers) are
used as biomarkers for polycyclic aromatic hydrocarbons exposure
[29]. In our study we used 2-naphthol as it seems to be related
to atmospheric pollutants. In particular, that related to Cigarette
consumption [27]. Animal studies have shown that NAP and its
metabolites, are embryotoxic and abortifacient [13].
H. Mirghani et al. / Toxicology Reports 2 (2015) 957–960 959
Table  2
Shows the transfer percentage and transfer index of 2-naphthol.Transfer percentage and transfer index were calculated up to 3 h of perfusion, data are presented as mean ± SEM
(n  = 6).
Perfusion time
(min)
Antipyrine
Transfer
percentage
2-Naphthol
Transfer
percentage
Transfer index
15 12.05 ± 2.79 4.46 ± 1.33 0.38 ± 0.12
30  25.55 ± 7.41 11.87 ± 2.36 0.46 ± 0.26
60  40.35 ± 6.32 11.82 ± 1.60 0.30 ± 0.09
120  30 ± 3.89  
240  52.10 ± 6.18
360  48.15 ± 3.10 
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eig. 1. Shows the mean (±sem) transfer of 2-naphthol (g/ml) across the placentas
howing the rapid drop from the maternal compartment and slow increase in the
etal  compartment (n = 6).
Interestingly, NPH was detected in placental tissue samples
btained prior to perfusion, indicating a signiﬁcant NAP environ-
ental exposure during pregnancy. The accumulation of 2-NPH
eems related to the gestational age. Singh et al. [28] observed
igher levels of PAH, including NPD, in pre-term placenta compared
o term placenta. This might be due to structural changes occurring
uring the early second half of pregnancy mainly the partial dis-
ppearance of the cytotrophoblast layer which reduce the placenta
arrier thickness [10]. Stabenau et al. [30], suggested that the accu-
ulation of NAP has greater effect on the functions of the liver
hat have higher metabolic activities, and those that have gaseous
xchange function. The placenta is known to have a high metabolic
ctivity [31]. Hence, the presence of NPH in unperfused placen-
al tissue and its rapid accumulation observed in our study might
ffect placental function. However, all neonates of pregnant women
nvolved in this study had a normal birth weight and no structural
nomalies. Nevertheless, there is increasing evidence that prena-
al exposure to PAH might have long term effects on neonates and
nfants. Rosa et al. [22] suggested that prenatal exposure to PAH is
ssociated with development of asthma later in life. More worrying
re the reports suggesting associated chromosomal aberrations in
he newborn and potential risk for cancer development later in life
20].
Our results illustrate NPH appearance in the fetal compart-
ent within 15 min. This could be due to lipophilic nature and
ow molecular weight of NPH [24]. PAH components with struc-
ures similar to NPH rapidly pass from food to milk through the
ammary epithelium [5]. Several factors might inﬂuence the rate
f transfer of any xenobiotic compound, including placental mem-
rane permeability, placental blood ﬂow, pH differences between
he maternal and fetal circulations, and protein binding proper-
ies of the compound itself. In addition, the placenta possesses
enobiotic-metabolizing capacity to metabolize a number of for-
ign compounds [12] which may  have an impact on the exposure16.68 ± 2.67 0.55 ± 0.05
15.89 ± 3.26 0.29 ± 0.06
17.01 ± 3.26 0.35 ± 0.05
of the fetus to foreign compounds. Coordinated induction of estro-
gen hydroxylase (EH) and catechol-O-methyl transferase (COMT)
by xenobiotics in ﬁrst trimester human placental explants, and
COMT enzyme activities appear to undergo a coordinated induc-
tion in cultured placental explants in the ﬁrst trimester [1]. The
limiting factor in sulphation reaction seems to be the activity of
sulphotransferase (ST) towards 2-naphthol.
In our study we observed that NPH transfer across the placenta
was at a rate signiﬁcantly lower than that of antipyrine throughout
the period of perfusion. From 60 min  the transfer reached a steady
state. This suggests that the method of transfer of NPH may  differ
from that of antipyrine, which is transferred across the placenta by
simple diffusion. This might suggest NPH is transferred by active
transport via the host of transporters expressed in the placenta.
Furthermore, the rate by which NPH increased in the fetal com-
partment was  at a much lower rate than its drop from the maternal
compartment. This might be due to the accumulation of NPH in pla-
cental tissue evident by the signiﬁcant higher NPH levels observed
in the perfused placenta cotyledon compared to levels in unper-
fused placental tissues. This ﬁnding supports the protective role
of the placenta against feto-toxic materials [32]. Animal studies
have shown that NPH accumulates in different body tissues such
as the liver, lung, and muscle at different rates [4,30]. However, its
elimination from the body seems to more rapid from organs that
have high metabolic activity such as the liver. This is believed to
be related to the activity of cytochrome P450 enzymes [30], which
seem to play the main role in metabolizing foreign toxins and chem-
icals from the placenta. They are found throughout pregnancy [10].
Similarly, other PAHs are metabolized by a group of Cytochrome
P450 oxidoreductase enzymes including CYP 1A2, 3A4 [1,36].
5. Conclusion
Our study suggests that pregnant women are exposed to high
levels of environmental NAP, and its metabolites accumulate in
term placentas. NPH has the ability to rapidly cross the placenta
from maternal to fetal compartment within 15 min. The placenta
seems to play a role in limiting the passage of NPH in the fetal com-
partment by acting as a chemical barrier. Our ﬁndings recommend
further studies to better understand how the placenta metabolizes
the 2-naphthol.
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